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Abstract 
 
Is Supplemental Leucine Intake Associated with Enhanced Post Exercise Muscle Protein 
Synthesis and Attenuated Muscle Protein Breakdown? 
 Knight AD, Benardot D, Thompson W, and Henes ST 
Introduction: The role of individual amino acids on protein synthesis and their impact 
on physical performance is of high importance to athletes and to those studying the 
science of sports nutrition. Leucine, one of three branched-chain amino acids, is a 
frequently researched amino acid because of its potential stimulatory effect on muscle 
protein synthesis (MPS) following exercise in humans.  
Purpose: Although there have been many studies conducted on leucine’s muscle 
stimulatory effect, questions remain as to the efficacy and feasibility of leucine as an 
MPS catalyst. Contributing to these questions are the widely varied dosing and timing 
strategies that different researchers have employed. It is the purpose of this thesis, 
therefore, to assess the differences in study protocols and shed light on the potential 
effectiveness on leucine as a MPS stimulator. Central to this issue is whether 
supplemental leucine intake is associated with enhanced post exercise MPS and, if so, 
what associated factors, including timing and level of intake, are most likely to influence 
this effect. 
Methods: A comprehensive review of the literature on leucine and its effect on MPS was 
performed.  Studies were organized into similar topics, with an assessment and summary 
of effect produced for each topic area.  A general conclusion was made that was based on 
the summary of each topic area. 
Results: Leucine is involved in protein metabolism regulation through its role in 
stimulating the mammalian target of rapamycin (mTOR) signaling cascade and by 
indicating energy and amino acid availability. It functions to initiate MPS and decrease 
muscle protein breakdown by downregulating the ubiquitin-proteasome system, 
lysosomal activity, and/or increasing circulating insulin.  
Conclusions: Supplementation with the amino acid leucine effectively enhances MPS 
and attenuates muscle protein degradation in humans following bouts of physical 
exertion. Leucine intake in amounts greater than that found in ~20g whole protein 
saturates MPS and increases leucine oxidation. For this reason, an upper limit of leucine 
intake should be established. While leucine successfully increases MPS, it remains 
unclear whether this translates to enhanced physical performance, an area that requires 
more studies to be conducted.     
Key Words: Leucine, protein turnover, muscle protein synthesis, amino acid 
supplementation
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Introduction
 
Improving physical performance is a goal for athletes and non-athletes alike. Thousands 
of research studies have been conducted with this specific purpose in mind. One 
noticeable contributor to enhanced performance is lean body mass (Reid et al., 2008). As 
a result of these studies, the effect of diet and specific substrate and nutrient consumption 
on muscle and lean body mass has become a highly researched field (Howald & 
Decombaz, 1983; Tipton & Wolfe, 2004; Burke et al. 2006; Lambert et al. 2004). In the 
course of this research, several possible ergogenic aids have been posited to enhance 
performance in athletes. The essential amino acid leucine has been identified as a key 
regulator in protein metabolism for over 30 years (Buse & Reid, 1975), but the 
biochemical basis for its effect, and its other prominent roles in vivo are still being 
examined at length (Norton & Layman, 2006; Roh et al. 2003; Li et al. 2011; Zanchi et 
al. 2012). This review focuses on the role of leucine in protein metabolism, especially 
synthesis, and its effects on several other contributors to physical performance. 
 
Protein turnover occurs as muscle protein constantly changes and remodels by 
synthesizing new proteins and breaking down existing proteins (Norton & Layman, 
2006). Throughout a typical day, the ratios of protein synthesis to breakdown vary 
significantly. Nutrients become available post-meal and protein synthesis and breakdown 
both increase, but protein degradation occurs to a lesser extent, resulting in a net positive 
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balance of protein turnover. During a prolonged period with no food consumption, 
protein synthesis decreases by 15 to 30%, resulting in a net catabolic period. That period 
of catabolism continues until adequate energy and amino acids are ingested to stimulate 
protein synthesis (Norton & Layman, 2006). Both exercise and nutrition have been found 
to strongly influence net muscle protein balance (Alvestrand et al., 1990; Morgan et al., 
1971; Rannels et al., 1974; Tipton et al., 2009).  Protein metabolism in skeletal muscle 
tissue is highly responsive to nutrient intake in healthy individuals and in addition to food 
ingestion, exercise can effectively alter protein turnover, as it stimulates both protein 
synthesis and protein breakdown (Biolo et al., 1995; Koopman et al., 2006).  Protein 
gains occur only as a result of positive net muscle protein over a given time period. 
Positive net muscle protein balance results either from increased muscle protein synthesis 
and/or decreased muscle protein degradation. For hypertrophy of muscle to take place, 
muscle protein synthesis (MPS) must surpass muscle protein catabolism (Coburn et al., 
2006). Consumption of amino acids through protein ingestion or intravenous injection is 
essential in accentuating post-exercise muscle protein synthesis. Contractile activity and 
availability of nutrients are strong modulators of exercise-induced adaptive responses 
(Moore et al., 2009; Wilkinson et al., 2008). Furthermore, lack of nutrient provision in 
timely proximity to high-intensity exercise bouts is possibly detrimental for maintenance 
or promotion of muscle mass (Coffey et al., 2011). 
 
The metabolic roles for amino acids go beyond serving solely as building blocks for de 
novo protein synthesis. They serve in many roles, but for the purposes of this discussion, 
amino acids also stimulate secretion of insulin, glucagon, growth hormone and IGF-1 
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(Wilcox, 2005). Reports show that co-ingestion of a protein hydrolysate with or without 
additional leucine with carbohydrate effectively increases the plasma insulin secretion in 
several populations, including endurance-trained athletes (van Loon et al., 2000). The 
complex mechanisms by which amino acids promote and/or enhance insulin secretion are 
diverse and are not yet fully understood. Like glucose-mediated insulin secretion, 
intracellular catabolism of the metabolizable amino acids increases availability of 
substrate for the tricarboxylic acid cycle. In the absence of food intake, net muscle 
protein balance will stay negative (Coburn et al., 2006). Therefore, muscle hypertrophy 
only occurs when sufficient food is consumed during post-exercise recovery. 
Carbohydrate ingestion post-exercise, on the other hand, increases circulating insulin 
concentrations, thereby reducing protein breakdown, but does not increase muscle protein 
synthesis rates per se.  
 
Availability of amino acids has been shown to be an important factor in promoting net 
protein synthesis (Coburn et al. 2006). Administration of protein/amino acids (>15g) 
following resistance exercise effectively increases muscle protein rates (Koopman et al., 
2007). Aside from their role in protein synthesis, amino acids play a key regulatory role 
as signaling molecules modulating muscle protein metabolism (Rennie, 2006). This is 
one reason why individuals who wish to enhance lean tissue mass must consume protein 
after exercising to gain a positive protein balance and capitalize on the muscle adaptive 
response. 
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Early studies showed that high concentrations of all amino acids stimulate protein 
synthesis and inhibit protein breakdown, particularly in skeletal muscle and specifically, 
the three branched-chain amino acids (BCAAs), leucine, valine, and isoleucine. One 
reason may be due to the fact that the BCAAs are the only essential amino acids oxidized 
primarily extrahepatically, and while most tissues can oxidize them, skeletal muscle is 
thought to be the principal site of branched-chain amino acid catabolism because of its 
mass (Buse & Reid, 1975; Ahlborg et al., 1974).  Of the three BCAAs, leucine alone has 
been seen as the most potent stimulator of protein synthesis and it has an oxidation rate 
higher than that of isoleucine or valine (Buse & Reid, 1975; Garlick & Grant, 1988). 
Leucine is an essential amino acid, meaning it cannot be synthesized de novo by humans, 
and must be acquired in the diet or supplemented as in many of the studies examined 
here. These early studies began the continuing series of investigations into leucine’s role 
in tissue protein mass, its mechanism of action, and its potential significance in 
enhancing muscle protein composition in healthy subjects or mediating muscle protein 
loss in states of catabolism (Garlick, 2005). Sufficient evidence points to leucine’s 
functions as a protein synthesis initiator, as a modulator of the insulin signal cascade, and 
even as a donor of nitrogen for alanine and glutamine production in the muscle. (Odessey 
et al., 1974; Preedy & Garlick, 1986; Garlick & Grant, 1988; Norton & Layman, 2006). 
 
In this thesis, the efficacy of leucine as a promoter of MPS will be examined, as well as 
its role in attenuating muscle protein breakdown (MPB). Leucine regulates protein 
synthesis in skeletal muscle, but also in other tissue as well, including cardiac and 
adipose tissue (Lynch et al., 2002; Roh et al., 2003; Suryawan et al., 2012). Whether or 
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not the increases seen in protein synthesis translate to improvements in physical 
performance or muscle hypertrophy remain to be seen. 
 
The relationship between exercise and leucine intake is another point that has been 
extensively researched, but remains debatable.  Resistance exercise produces increases in 
protein synthesis that manifest shortly after exercise and continue for up to 48 hours 
(Phillips, 2004). Does leucine intake, supplemental or dietary, enhance this already 
increased protein synthetic response? 
 
Another question posed by many is in regard to the safety of individual amino acid 
intake. It has long been recommended that dosing of solo AAs is unnecessary and 
potentially harmful. If this is the case with leucine, should only dietary sources be 
recommended? The dose threshold of leucine and other EAAs is not clear, and neither is 
the efficacy of leucine in conjunction with other substrates, dietary or not. Studies have 
shown that elevations in serum EAAs were responsible for increases in muscle protein 
synthesis independent of insulin or IGF-1 changes (Cuthbertson et al., 2004). Larger 
doses of leucine have been shown to be significantly more effective at stimulating muscle 
protein responses than doses equivalent to the average dietary intake of leucine (Glynn, 
2010). Also, leucine levels must be adequately high to function in signaling and 
metabolic roles since structural roles must be satisfied a priori, and leucine’s capacity to 
signal and function as an oxidative substrate is based on sufficient intracellular 
concentration (Li et al., 2011). Most potential advocates for leucine supplementation will 
require a specific, numeric dose-response threshold.  
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Assuming an appropriate dose based on controlled therapeutic studies is reached, timing 
and length of supplementation is still necessary for initiation of therapy in any individual. 
Since it is well established that metabolic pathway thresholds are overwhelmed by bolus 
doses greater than ~20-25g protein and equivalent AA intake, leucine intake in bolus 
doses greater than these equivalents are not recommended (Moore et al., 2009; 
Churchward-Venne et al., 2012). Timing throughout a 24-hour period and in relationship 
to exercise and periods of inactivity are equally important (Adechian et al. 2012). Few 
studies have assessed the effects of long term supplementation, but initial results have 
indications for human consumption. 
 
One major factor that influences physical performance is not muscle hypertrophy or 
physical endurance and strength, but mental stamina (Portier et al., 2008). It is apparent 
that causes of fatigue are multifactorial, influenced by operations occurring in the 
periphery and the central nervous system. This idea is posited in the central fatigue theory 
which suggests that the onset of fatigue in prolonged exercise can be attributed to 
changes in serotonin, dopamine, and noradrenaline concentrations. The synthesis of these 
chemicals is largely dependent on AAs that use the same transporter through the blood-
brain barrier as the BCAAs, meaning that the plasma concentration ratio of these AAs is 
a significant indicator of neurotransmitter synthesis (Meeusen & Watson, 2007). Leucine 
in elevated concentrations may stymie these processes contributing to fatigue. 
 
Many studies have been designed to study leucine and its potential attenuating effect on 
sarcopenic muscle have potential indications for older athletes and those in which muscle 
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wasting from disease are a concern. Data indicate that aging leads to a diminished muscle 
protein accretion after EAA ingestion (Katsanos et al., 2006). Aging is associated with a 
blunted response to EAA intake and thus, the effects of leucine on MPS. Other studies 
have shown leucine supplementation increases the potential for muscle protein synthesis 
in older adults and may supplement an otherwise insufficient or poor quality of dietary 
protein more biologically available for muscle tissue growth and repair (Casperson et al., 
2012).   
 
Despite its popularity over the years as a potential muscle enhancer and the multitude of 
studies performed, the efficacy of leucine is still controversial. One reason for the lack of 
consensus is the variability of methods utilized in these studies, and the inability to 
generalize research results across the board. Investigation methods vary on dose 
administered, additional substrates co-administered, timing prior to or following exercise, 
length of supplementation, length of exercise, type of exercise, subjects tested,  route of 
administration, etc. Study results from different metabolites of leucine, like 
hydroxymethylbutyrate (HMB), cannot be generalized to leucine as they only account for 
only 5–10% of the metabolites produced from the degradation of leucine (Van Koevering 
& Nissen, 1992). For these reasons, the question of whether supplemental leucine intake 
is associated with enhanced post exercise muscle protein synthesis remains unclear. 
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Hypotheses 
 
Hypothesis 1: Leucine stimulates muscle protein synthesis significantly more than other 
amino acids. 
Null Hypothesis 1: Leucine does not stimulate muscle protein synthesis 
significantly more than other amino acids. 
 
Hypothesis 2: Leucine attenuates muscle protein degradation following resistance 
exercise.  
Null Hypothesis 2: Leucine does not attenuate muscle protein degradation 
following resistance exercise. 
 
Hypothesis 3: Leucine intake enhances physical performance. 
Null Hypothesis 3: Leucine does not enhance physical performance. 
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Review of Literature
 
Leucine and Muscle Protein Synthesis 
 
One of the very first studies to specifically look at leucine as a possible muscle protein 
metabolism regulator was published in 1975. Buse and Reid (1975) hypothesized that at 
least one of the three branched chain amino acids (BCAAs) was rapidly oxidized and its 
stores in muscle cells depleted, serving as a catabolic signal. They surmised that leucine 
acts as a regulator of protein turnover through its depletion and/or through its presence. 
 
The study utilized incorporation of radiolabeled precursors into muscle proteins. A 
compound of the BCAAs stimulated the incorporation of lysine into proteins. When 
tested independently, valine was ineffective, isoleucine was inhibitory, but leucine 
increased the specific activity of muscle proteins with or without the introduction of 
insulin. Preincubation with leucine improved the specific activity of muscle proteins and 
preincubation with other amino acids did not exhibit this same effect. The lysine 
concentration in the tissue water decreased during incubation with leucine, signifying that 
leucine also inhibited protein breakdown. During incubation with tyrosine the addition of 
leucine increased the specific activity of muscle proteins, while the specific activity of 
intracellular tyrosine remained constant and its concentration decreased, suggesting that 
leucine also promoted protein synthesis.  
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Researchers concluded that the muscle cell concentration of leucine may play a role in 
regulating muscle protein metabolism and influence the transition to negative nitrogen 
balance during fasting, uncontrolled diabetes, and the posttraumatic state. Leucine may 
play a pivotal role in the protein-sparing effect of amino acids. Despite the encouraging 
findings, authors of this study closed by adding the following caveat:  
“…studies of the potential protein anabolic effect of leucine…would have to take 
into account the possible deleterious effects that amino acid imbalance or 
antagonism may produce in vivo” (Buse & Reid, 1975).  
This early warning is especially applicable today in our world of over-supplementation 
and amino acid mega-dosing. 
 
Similar early studies demonstrated that high concentrations of amino acids stimulated 
protein synthesis and inhibited protein degradation, particularly in skeletal muscle, but 
also in cardiac muscle (May & Buse, 1989). Specifically, it was shown in heart muscle 
that the stimulation by amino acids could be reproduced with only the three BCAAs, and 
as seen in the isolated diaphragm muscle, leucine alone stimulated protein synthesis. 
They found that net uptake of BCAAs was observed suggesting that these AAs were 
utilized as an oxidative substrate and the increased rate of protein anabolism was due to a 
direct effect on the protein synthesis pathway rather than an indirect effect from simply 
increasing energy levels in the cell. Li and Jefferson (1978) found when they omitted 
BCAAs from an AA mixture infused in rat skeletal muscle, the remaining AAs, even at 
five times their normal plasma levels, had no effect on protein turnover. Another study 
demonstrated that the ratio of individual BCAAs to the amount of leucine was more 
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critical to nitrogen-sparing than the total percentage of BCAAs infused (Bonau et al., 
1984).  Leucine intravenously infused during a prolonged fasting state resulted in 
decreased plasma amino acid levels, nitrogen balance improvement and no difference in 
excretion of 3-methylhistidine, which was found to suggest muscle protein synthesis 
stimulation (Sherwin, 1978). This group of studies began a series of investigations into 
leucine’s role in protein mass regulation and its mechanism of action (Morgan et al., 
1971; Rannels et al., 1974; Li & Jefferson, 1978).  
 
Table 1: Summary of studies related to effect of mixed AA supplementation on muscle 
protein synthesis 
Reference Population Design Findings 
Morgan et al. 
(1971) 
Rats Protein synthesis was 
measured using 
incorporation of 14C-
phenylalanine into 
heart protein.  
Protein synthesis 
increased when AA levels 
increased from 1-5 times 
normal levels. 
Buse & Reid 
(1975) 
Rats Muscle proteins were 
incubated in BCAAs 
and tracer 
incorporation was 
observed. 
Leucine alone increased 
protein specific activity 
and increased MPS to the 
greatest extent. 
Li & Jefferson 
(1978) 
Rats Fasted rats were 
infused with BCAAs. 
MPS was stimulated to a 
greater degree than rats 
infused with an AA 
mixture without BCAAs. 
Bonau et al. 
(1984) 
25 post-
operative 
males with 
bladder cancer. 
Different 
concentrations of 
BCAA IV solutions 
were administered for 7 
days. 
The high leucine group 
had greater nitrogen 
balance and less muscle 
catabolism. 
Preedy & 
Garlick (1986) 
Rats Fasted rats were refed 
by intragastric or IV 
infusion of an AA plus 
glucose mixture.  
MPS was suppressed by 
anti-insulin injection. 
Garlick & 
Grant (1988) 
Rats AA and insulin 
mixtures were given 
between meals. 
BCAAs increased MPS 
over insulin infusion or 
non-BCAAs. 
Louard et al. 10 humans BCAAs were infused MPB was suppressed, but 
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(1990) intravenously. MPS was not increased. 
Schena et al. 
(1992) 
16 humans Participants trekked 21 
days at high altitude 
and took either BCAA 
or placebo 
supplements. 
BCAA supplementation 
increased MPS during 
chronic hypobaric 
hypoxia. 
Blomstrand et 
al. (2006) 
Humans BCAAs were given to 
subjects after resistance 
exercise. 
BCAAs stimulated the 
signaling pathways that 
control MPS. 
Coffey et al. 
(2011) 
8 healthy 
young males 
Participants performed 
sprint cycling after 
ingesting nutrients or 
placebo. 
Nutrient provision 
(including leucine) 
increased anabolic 
signaling and MPS. 
AA: Amino Acids; BCAAs: Branched Chain Amino Acids; MPS: Muscle Protein 
Synthesis; IV: Intravenous; MPB: Muscle Protein Breakdown 
 
In the studies performed with mixed AAs or BCAAs (Table 1), there was consensus that 
MPS was stimulated. Most studies found that BCAAs increased MPS to a greater degree 
than mixed AAs, or by using less substrate. One study listed in Table 1 did not see 
increased MPS (Louard et al., 1990), but MPB was attenuated by BCAA infusion. Under 
many different types of conditions, and in both rat and human populations, MPS was 
stimulated by BCAA intake. 
 
Early work produced considerable advances in the comprehension of the signal 
transduction pathways involved in the control of muscle protein synthesis by amino acids 
and insulin. The physiological role of leucine is then to act in combination with insulin to 
activate the “switch” that stimulates muscle protein synthesis when availability of energy 
and amino acids from food is signaled (Preedy & Garlick, 1986). The advantage of this 
mode of regulation is that the switch calls for both amino acids, namely leucine, and 
insulin to be present concurrently, so is only activated in ideal conditions (Preedy & 
Garlick, 1986; Balage et al., 2011). Also contributing to the evidence for leucine’s 
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efficacy, when compared with glucose infusion, protein synthesis was stimulated equally 
by a complete mixture of AAs, by only EAAs, and by only the BCAAs (Garlick & Grant, 
1988). This demonstrates that specifically the BCAAs enhance insulin sensitivity of 
muscle protein synthesis pathways.  
 
An early study specifically demonstrated the ability of orally administered leucine to 
stimulate recovery of skeletal muscle protein synthesis after exercise (Anthony et al., 
1999). Rather than simply providing post-exercise substrate, this study showed that 
leucine alone was effective since feeding carbohydrate alone did not increase protein 
synthesis rates above those of rats fasting post-exercise. Plasma insulin was elevated 
similarly in rats fed either the macronutrient-mixed meal or the carbohydrate meal, 
demonstrating that insulin acts together with another factor of the mixed meal to 
stimulate protein synthesis. The authors posited that the inability of researchers in 
previous animal studies to demonstrate that leucine stimulates skeletal muscle protein 
synthesis was due to an inadequate leucine quantity administered to the animals. A higher 
dose than previous was chosen in this study to maximize the effects of leucine. The 
findings here suggest leucine stimulation of muscle protein synthesis is dose dependent 
(Anthony et al., 1999).  
 
Oral administration of a bolus amount of leucine equivalent to the daily intake (1.35g/kg 
body weight) has been found to enhance skeletal muscle protein synthesis in studies with 
food-deprived rats (Crozier et al., 2005). The dose of leucine used in previous studies is 
quite large, equal to what is consumed in a 24-hour period by rats when allowed free 
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access to standard lab chow. Since leucine is relatively insoluble, such a large dose may 
not be generalizable to human studies. But this study was able to demonstrate that smaller 
doses of leucine administered orally were successful in stimulating muscle protein 
synthesis as well (Crozier et al., 2005).  
 
Plasma leucine concentrations significantly increased in rats fed one meal each day that 
contained proteins (i.e., β-lactoglobulin) high in leucine. As a result, MPS significantly 
improved in these rats fed a leucine-rich diet. And most notably, the increased MPS 
effect was maintained even after the 30-day supplementation. Additional studies are 
needed to determine the length of supplementation that would produce a significant gain 
in muscle protein (Rieu et al., 2007). 
 
Another recent study showed that whey protein doses in insufficient quantities to 
maximally effect muscle protein synthesis (Moore et al., 2009), supplemented with 
leucine resulted in an increase in rates of MPS equal to those usually seen following 25g 
whey protein doses. However, contrary to the authors’ hypothesis, supplementation of a 
low dose whey protein with an EAA mixture absent of leucine also resulted in 
stimulation of MPS no different from what was seen in the leucine-supplemented whey 
protein. These findings contradict the hypothesis that MPS stimulation is directly 
proportional only to the rise in leucine in the blood. The investigators postulated that 
while leucine is potently able to stimulate MPS, only a small amount (~0.75g) is 
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necessary to maximally stimulate MPS given that other EAAs are present in sufficient 
quantities (~8.5g) (Churchward-Venne et al., 2012). 
 
One study that examined the physiological mechanism of leucine efficacy identified 
messenger RNA translation via the activation of a variety of intracellular signaling 
proteins, especially those of the mTOR signaling cascade as the primary level of 
regulation of acute muscle protein synthesis.  Stimulation of muscle protein synthesis 
after food intake or resistance exercise is accompanied by increased phosphorylation, and 
activity, of the mTOR signaling pathway, and thus, protein synthesis. This biochemical 
pathway has been identified in several studies as a possible mechanism by which leucine 
increases MPS (Blomstrand et al., 2006; Casperson et al., 2012; Coffey et al., 2011; 
Dreyer et al., 2008; Li, 2011).  This study examined the response of protein synthesis and 
total body leucine oxidation to increasing protein intake after an acute bout of resistance 
exercise. Increasing protein intake stimulated muscle and plasma albumin protein 
synthesis in a dose-dependent manner up to 20g dietary protein, after which there was a 
significant stimulation of whole-body leucine oxidation and no added increase in protein 
synthesis (Moore et al., 2009). 
 
Other studies have not seen the efficacy of leucine as described by the aforementioned 
researchers. Some saw no difference between the effects of leucine alone and all EAAs 
(Bohé et al., 2003; Smith et al., 1992,1998; May & Buse, 1989); while others failed to see 
the purported protein synthetic effects of leucine administration in vivo (McNurlan et al., 
1982; Louard et al., 1990). 
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Table 2:  Summary of studies related to the effect of leucine supplementation on 
muscle protein synthesis 
Reference Population Design Findings 
Buse & Reid 
(1975) 
Rats AA mixture added to 
media to stimulate 
incorporation of lysine 
into proteins. 
Leucine stimulated 
protein synthesis, and 
mixtures without leucine 
did not. 
Sherwin (1978) Obese and 
Non-obese 
humans. 
Leucine was given 
intravenously between 
meals and after fasting.  
Leucine infusion 
stimulated MPS and 
attenuated MPB. 
McNurlan et al. 
(1982) 
Rats Leucine was 
administered to rats that 
were either fed, starved, 
or protein-deprived. 
Leucine had no effect on 
MPS in any tissues. 
Smith et al. 
(1992)  
7 males Participants received a 
constant infusion of 
valine and a flooding 
dose of leucine 
intravenously. 
Synthesis rates were 
higher after flooding, 
regardless of the 
precursor chosen. 
Smith et al. 
(1998) 
23 young 
males 
Flooding doses of EAAs 
were given and effects 
on tracers were 
observed. 
Flooding with EAAs 
increased tracer 
incorporation. 
Anthony et al. 
(1999) 
Rats Rats were divided into 
groups by exercise and 
diet. 
Leucine stimulated MPS 
following exercise, 
independent of plasma 
insulin. 
Crozier et al. 
(2005) 
Rats Fasted rats were given 
bolus doses of oral 
leucine. 
Leucine stimulated MPS. 
Rieu et al. 
(2007) 
Rats Aging rats were fed 
diets with differing 
amounts of leucine 
content. 
The leucine-rich diet 
stimulated MPS more 
than others & maintained 
the effect >30 days. 
Dreyer et al. 
(2008) 
16 males Participants ingested 
either placebo or 
leucine-enriched 
solution after resistance 
exercise. 
Enhanced signaling 
increased MPS after the 
leucine-enriched solution 
was consumed. 
Moore et al. 
(2009) 
6 young 
males 
Participants consumed 
differing amounts of 
protein after resistance 
exercise. 
20g protein was sufficient 
to maximally stimulate 
MPS. Excess intake led 
to oxidation. 
Churchward-
Venne et al. 
(2012) 
24 males Participants consumed 
differing amounts of 
whey with or without 
Low doses of whey with 
added leucine stimulated 
MPS to the same degree 
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added leucine after 
resistance exercise. 
as larger whey doses. 
Casperson et al. 
(2012) 
Older 
humans 
Meals were 
supplemented with 
leucine for 2 weeks. 
Increased stimulation of 
the signaling pathways 
that control MPS was 
seen. 
AA: Amino Acids; MPS: Muscle Protein Synthesis; MPB: Muscle Protein Breakdown; 
EAAs: Essential Amino Acids 
 
In these studies, performed to assess the effect of leucine intake on MPS, the consensus 
was that increased stimulation of MPS was seen after leucine supplementation. The 
majority of these studies found that leucine increased MPS to a greater degree than a 
control or a similar mixture containing less leucine. Three studies of those examined here 
did not see increased MPS, or saw the same effects induced by other EAAs. In 
conclusion, it has been shown that under many different types of conditions, and in both 
rat and human populations, MPS is stimulated by leucine intake or infusion. 
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Leucine and Muscle Protein Degradation 
 
Carbohydrate and protein/amino acid ingestion during exercise recovery is part of an 
effective strategy to stimulate muscle protein synthesis, inhibit protein breakdown and, as 
a result, to augment net muscle protein accretion (Norton & Layman, 2006). Protein 
catabolism is stimulated to a greater extent than protein synthesis following exhaustive 
exercise, interestingly enough. Consequently, athletes need to consume sources of protein 
post-exercise to achieve a positive protein balance and maximize their skeletal muscle 
adaptive response (Koopman et al., 2007). While protein synthesis has been the focus of 
countless studies involving leucine (Casperson et al., 2012; Coffey et al., 2011; 
McNurlan et al., 1982; Pasiakos et al. 2011), protein degradation has not been a specific 
area of concentration. Nagasawa et al. (2002) found that postprandial protein degradation 
suppression was primarily due to amino acids, specifically leucine. Since muscle 
hypertrophy occurs as a result of either increased protein synthesis or decreased protein 
breakdown, leucine’s effect on protein degradation is of great interest.  
 
Several studies have examined the effect of leucine supplementation on muscle protein 
breakdown and post-exercise muscle recovery. One study evaluated the impact of BCAA 
supplementation in adult hikers during a 21-day trek at high altitudes. They concluded 
that BCAA supplementation may prevent muscle loss during the chronic hypobaric 
hypoxemic conditions (Schena et al., 1992). The anabolic effect of leucine has been 
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attributed to its inhibition of protein degradation by Nair et al. (1992), but interestingly, 
they found no evidence that leucine stimulated muscle or whole body protein synthesis. 
 
Baptista et al. (2010) attempted to elucidate the mechanisms behind leucine’s suppression 
of protein catabolism found leucine supplementation attenuates muscle wasting by 
downregulating the ubiquitin-proteasome system (UPS), which drives protein 
degradation. The authors noted, however, that leucine supplementation did not restore 
decreased protein synthesis that followed immobilization of rats in this study. This 
suggests the protective effect seen in leucine supplementation is mediated by 
downregulation of UPS gene expression, and not stimulation of protein synthesis. The 
authors posit that leucine may be utilized as a therapeutic supplement for those faced with 
long periods of immobilization following surgery, such as joint reconstruction. 
In contrast, Sugawara et al. (2009) showed that leucine feeding in a protein deprived state 
minimized protein catabolism. They suggested that downregulation of activity of the 
lysosomal pathway, rather than UPS, is responsible for the muscle wasting attenuation 
seen in rats with a leucine-rich diet. In addition, the study showed protein degradation 
was significantly suppressed and muscle protein synthesis was not enhanced. This 
suggests that instead of protein synthesis, reduction in muscle is inhibited by leucine and 
regulated by protein degradation. When dietary protein is scarce, since amino acids are 
used as material to synthesize muscle protein, substrate for muscle synthesis is also 
deficient. The amount of amino acids supplied by muscle protein breakdown may not be 
sufficient for protein synthesis. In contrast, material is not necessary for the suppression 
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of protein degradation. According to the findings in these studies, muscle protein 
degradation is a key factor in regulation of muscle turnover (Sugawara et al., 2009). 
 
One explanation for leucine’s observed ability to abate MPB is in its stimulation of 
plasma insulin. A higher leucine concentration than that typical of high-quality proteins 
was found to produce transient decreases in MPB and enhance mTORC1 signaling, 
which may induce protein synthesis in muscle (Dreyer, 2008; Li et al., 2011). However, 
the observed changes did not translate into significant improvements in overall muscle 
protein balance. Leucine in bolus doses, like many nutrients, causes an increase in 
circulating insulin. Since insulin decreases MPB (Louard et al., 1992), the insulin 
response in the leucine supplemented group may have contributed to the observed 
decreases in MPB (Glynn et al., 2010). Another study found administration of leucine 
suppressed protein degradation even without insulin action, to which this effect can often 
be attributed (Nagasawa et al., 2002). 
 
Another study found that high doses of supplemental leucine (>20g) did not to prevent an 
increase in muscle damage biochemical markers following eccentric-based resistance 
exercise, but that supplementation may have aided in the maintenance of force output 
(Kirby et al., 2012). Another study researched the isolated effects of leucine added to a 
carbohydrate beverage on recovery from resistance exercise. Biochemical markers of 
muscle damage like creatine kinase (CK) and LDH, as well as athletes’ perception of 
delayed onset muscle soreness (DOMS) and leucine’s possible attenuation of these was 
examined. Researchers found that there were no significant differences in CK, LDH, 
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DOMS, and number of squat repetitions in subjects who consumed pre- and post-exercise 
carbohydrate beverages with or without leucine. The addition of 45 mg/kg leucine to 
carbohydrate beverages did not attenuate blood markers of exercise-induced muscle 
damage or participants’ perception of DOMS (Stock et al., 2010). 
 
Decreases in protein synthesis and/or increases in protein degradation also occur during 
tumor development. These changes induce skeletal muscle loss, fatigue, weakness, and 
atrophy.  While physical exercise can be an effective part of the rehabilitation of cancer 
patients, any compounded effects from leucine on decreased MPB are significant. The 
promising effects of leucine supplementation give rise to interest in leucine’s use for 
individuals in catabolic disease states. Results in rats show that exercise and/or leucine-
supplementation led to an improvement in lean body mass due to attenuation of protein 
breakdown, maintenance of total muscle protein content, and increase in the muscle 
myosin content (Salomão et al., 2010). 
 
Table 3: Summary of studies related to effect of leucine supplementation on muscle 
protein breakdown 
Reference Population Design Findings 
Schena et al. 
(1992) 
16 humans Participants trekked 21 days 
at high altitude and took 
either BCAA or placebo 
supplements. 
BCAA supplementation 
decreased muscle loss 
during chronic 
hypobaric hypoxia. 
Nair et al. 
(1992) 
6 healthy 
males 
Leucine or saline was 
infused intravenously. 
Leucine decreased 
MPB across several 
muscle sites. 
Nagasawa et 
al. (2002) 
Rats Rats were fed diets with 
differing protein 
compositions or a leucine 
diet. 
Leucine was able to 
decrease the rate of 
MPB. 
Koopman et 
al. (2007) 
8 elderly 
males 
Crossover design where 
participants consumed a 
Coingestion of leucine 
did not attenuate MPB. 
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control diet or one 
supplemented with leucine 
after exercise. 
Sugawara et 
al. (2009) 
Rats Rats were fed a protein-free 
diet for 7 days and 
supplemented with leucine. 
Leucine 
supplementation 
inhibited MPB. 
Baptista et 
al.(2010) 
Rats Rats were supplemented 
with leucine during hind 
limb immobilization.  
Leucine 
supplementation 
inhibited muscle 
wasting. 
Glynn et al. 
(2010) 
14 humans Participants consumed 
EAAs with normal or high 
leucine content. 
Leucine 
supplementation 
showed a modest 
decrease in MPB. 
Stock et al. 
(2010) 
20 trained 
humans 
Participants performed 
resistance exercise and 
consumed a leucine 
supplemented beverage 
before and after. 
Leucine 
supplementation did not 
attenuate MPB. 
Salomão  et 
al. (2010) 
Tumor-
bearing rats 
Rats were divided into 
groups and performed 
exercise or did not, and 
consumed a leucine-rich 
diet or did not. 
Leucine, in 
coordination with 
exercise, decreased 
MPB. 
Kirby et al. 
(2012) 
27 males Participants performed drop 
jumps and consumed a 
placebo, leucine, or nothing. 
Leucine 
supplementation did not 
attenuate MPB. 
Nelson et al. 
(2012) 
12 males Participants performed high 
intensity endurance exercise 
and subsequently ingested 
leucine/protein supplement 
or control. 
The high leucine dose 
in the supplement 
saturated BCAA 
metabolism, increased 
leucine oxidation and 
attenuated MPB. 
BCAA: Branched Chain Amino Acids; MPB: Muscle Protein Breakdown; EAAs: 
Essential Amino Acids 
 
In the studies (see Table 3) performed to assess the effect of leucine supplementation on 
MPB, the consensus was that attenuation of MPB was observed. Most studies found that 
leucine ingestion inhibited MPB to a greater degree than a control or a similar mixture 
containing less leucine. The studies where leucine supplementation was seen to be 
effective utilized long-term ingestion, or were consumed in conjunction with exercise. 
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Three studies (Koopman et al., 2007; Stock et al., 2010; Kirby et al., 2012) of those 
examined here (Table 3) did not see decreased MPB. Interestingly, all three of those 
studies focused on the ability of leucine to decrease MPB through ingestion post-
exercise. In conclusion, it has been shown that under many different types of conditions, 
and in both rat and human populations, MPB can be attenuated by leucine intake or 
infusion. 
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Dietary versus Supplemental Intake 
 
In the world of nutrition and exercise, the notion that “if a little is good, a lot is great” has 
been long held. For this reason, the use of supplements and megadoses of many nutrients 
has skyrocketed in recent years. Many individuals consider their diets healthy, but want 
to enhance muscle synthesis and think supplementation may be the correct route. 
Previous studies have utilized both dietary and supplemental sources of leucine, but none 
have directly compared the two sources. Beyond the obvious question of safety, the 
question begs, is this practice necessary to achieve desired results? 
 
The concept of ingesting an isolated AA to stimulate MPS in the absence of an 
abundance of other AAs is not new. However, since protein is comprised of multiple 
AAs, a homogenous AA substrate would be unable to build muscle in the absence of 
another AA source. If leucine were able to independently stimulate MPS, substrate would 
be drawn from the intracellular AA pool. If there is sufficient delivery of AAs, synthesis 
should continue. However, in vivo, intramuscular AA concentrations fall as seen in 
studies on the effects of leucine infusion on human muscle (Alvestrand et al., 1990). 
After initial stimulation of anabolism, the concentration of all other AAs fell and leucine 
oxidation rose, likely because complete proteins could no longer be synthesized 
(Alvestrand et al.,1990). Leucine-rich amino acid mixtures are more effective than 
leucine alone at improving muscle mass and performance, suggesting the efficacy of 
leucine is dependent on the presence of other amino acids (Balage et al., 2011; Preedy & 
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Garlick, 1986). Likewise, Glynn et al. (2010) found no differences in MPS despite 
significantly higher extracellular concentrations of leucine in one study. 
If the biggest factor affecting MPS is AA availability, then dietary intakes of protein 
should serve to provide adequate substrate for ongoing muscle synthesis. One study 
specifically assessed the impact of leucine derived from complete meals on MPS 
stimulation. Rats were fed diets of differing protein content from either wheat or whey 
sources. Given equal protein intakes, whey protein increased MPS by as much as 52% 
more than wheat protein. The authors concluded that postprandial mTOR signaling and 
MPS stimulation is primarily directed by leucine, but the response duration is influenced 
by additional factors (Norton et al., 2009). 
 
Other studies have shown MPS becomes saturated when blood EAAs rise above 50-80% 
greater than the fasted state (Alvestrand et al., 1990). Observers found that the 
concentration of serum urea increased dramatically at high rates of AA infusion, due to 
the increase of hepatic catabolism of AAs delivered in excess of bodily ability to utilize 
them for muscle (Bohé et al., 2003). Others have agreed that there is little evidence that 
moderate physical activity increases protein requirements beyond those achieved by 
eating a normal diet that satisfies daily nutrient requirements (Rennie et al., 2006; Glynn 
et al., 2010). Provision of exogenous BCAAs may stimulate MPS but the effect is likely 
to be transitory given the “muscle-full” phenomenon already mentioned (Rennie et al., 
2006). 
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In contrast, some studies suggest leucine supplementation may improve muscle protein 
synthesis in response to lower protein meals (Casperson et al., 2012; Churchward-Venne 
et al., 2012). Following exercise, a suboptimal dose of protein high in leucine content or a 
mixed nutrient meal supplemented with leucine enhances MPS (Rieu et al., 2003; 
Churchward-Venne et al., 2012). Casperson et al. (2012) found that supplementing the 
daily meals of older adults for two weeks with 4g leucine increased FSR and anabolic 
signaling.  
 
The evidence from these studies suggests consumption of free leucine versus a dietary 
protein leads to an imbalance between leucine signaling and AA availability. This 
discrepancy in the initiation of MPS signaling pathways and delayed, or deficient, 
availability of AAs as substrates may even explain why MPS is stimulated for a short 
duration in many of these studies and did not convert to significant muscle accretion 
(Dardevet et al., 2012) 
 
 
Table 4: Summary of studies related to dietary intake of leucine or supplementation  
Reference Population Design Findings 
Alvestrand et 
al. (1990) 
12 females Participants were infused 
with leucine 
intravenously. 
Plasma and intracellular 
levels of AAs decreased, 
and 40% of excess 
leucine was oxidized. 
Bohe et al. 
(2003) 
21 humans Participants were infused 
with mixed AAs at a rate 
240% above basal levels. 
MPS became saturated at 
high concentrations of 
intramuscular EAAs. 
Rennie et al. 
(2006) 
Humans Participants were infused 
with mixed AAs or 
leucine. 
Leucine stimulated MPS 
to the same extent as 
complete meals. 
Norton et al. 
(2009) 
Rats Rats consumed diets with 
differing leucine content. 
Higher leucine content of 
meals correlated to peak 
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activation of MPS. 
Glynn et al. 
(2010) 
14 humans Participants consumed 
EAAs or EAAs with 
increased leucine 
content. 
Leucine content in 10g 
EAAs is sufficient to 
maximize MPS. 
Casperson et al. 
(2012) 
8 older 
humans 
Meals were 
supplemented with 
leucine for 2 weeks. 
Leucine improved MPS 
in response to lower 
protein meals. 
Churchward-
Venne et al. 
(2012) 
24 males Participants completed 
resistance exercise and 
consumed varying doses 
of whey supplemented 
with leucine or EAAs 
without leucine. 
Low doses of whey 
supplemented with 
leucine or EAAs 
stimulated MPS to the 
same degree as larger 
doses. 
Nelson et al. 
(2012) 
12 males Participants performed 
high intensity endurance 
exercise and 
subsequently ingested 
leucine/protein 
supplement or control. 
The high leucine dose in 
the supplement saturated 
BCAA metabolism, 
increased leucine 
oxidation and attenuated 
MPB. 
AAs: Amino Acids; MPS: Muscle Protein Synthesis; EAAs: Essential Amino Acids; 
BCAA: Branched Chain Amino Acid; MPB: Muscle Protein Breakdown 
 
In these studies, performed to assess the effect of leucine supplementation and/or dietary 
intake, the general consensus was that leucine intake in excess of the amount found in 
adequate whole protein is unnecessary. Most studies found that leucine supplementation 
in addition to protein intake saturated metabolism and leucine oxidation resulted. The 
studies where leucine supplementation was seen to be additive were in conjunction with 
lower protein doses, or supplementation was seen to have the same effect as complete 
meals. In summary, research has shown that excessive intake of leucine in addition to 
adequate protein ingestion is unnecessary to stimulate MPS. 
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Timing, Dosing, and Long Term Effects 
 
Researchers have speculated on the specific intake of leucine that constitutes an adequate 
dose to promote MPS. Churchward-Venne et al. (2012) reported that, leucine ingestion in 
larger amounts than that found in a saturating dose (20-25g whey protein containing 2.5-
3g leucine), would not be likely to promote a further increase in MPS magnitude or 
duration. The authors cautioned that as the data were taken from young healthy men 
(weighing ~86 kg), the dose of protein necessary to be maximally effective could be far 
different in a ~50 kg female gymnast or a 120 kg bodybuilder.  
 
A review by Rennie et al. (2006) similarly stated that there is little evidence that high 
rates of physical activity increase protein requirements beyond those achieved by eating a 
normal diet that fulfills energy requirements.  They acknowledged that providing 
supplemental leucine will stimulate MPS, but the effect will likely be transitory given the 
“muscle-full” phenomenon. The researchers posited that amino acid administration that 
mimics meal feeding would allow the muscle fullness set point to be modified to increase 
anabolism. Another reason to restrain dosing to modest levels is that amino acids have 
effects on protein synthesis and breakdown within a narrow range of concentration as the 
daily variation in the blood is only ~ ±50 % of the daily mean (Bergstrom et al., 1990). 
 
More recent evidence points to saturation of phosphorylation of initiation factors and, as 
stated previously, decreased sensitivity of signaling as the mechanism behind leucine’s 
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seeming decrease in efficacy. Researchers examined rat liver and skeletal muscle after 
administration of leucine, ranging from 0.169 to 1.35 g/kg of body weight. In skeletal 
muscle, phosphorylation reached a plateau at 0.675 g/kg of body weight. The mTOR 
signaling sensitivity to leucine in the skeletal muscle appeared to be higher than that in 
the liver (Yoshizawa et al., 2013). 
 
Aside from leucine, there may be other EAAs that can stimulate MPS. Valine, 
phenylalanine and threonine have each been shown to increase human MPS when given 
in a flooding dose (Smith et al., 1998). While the proposed effects of mega-doses of other 
EAAs may hold true, the relative efficiency of much smaller doses of leucine indicates 
greater efficacy and potency.  
 
Despite possible benefits of supplementation with leucine, some adverse effects have 
been seen related to doses administered. Effects reported include reduced food intake 
(Blouet et al., 2009), imbalance of other BCAAs (Allen & Baker 1972), and decreased 
growth and immune response in pigs (Gatnau et al., 1995). In contrast, Nguema et al. 
(2007), found no changes in food intake associated with leucine supplementation. Since 
the leucine dose necessary for increased plasma leucine concentration is not 
supraphysiological, it is unlikely to suppress appetite and reduce whole food intake. 
 
The increase in blood AA concentrations postmeal lasts ~3 hours, (Bergstrom et al., 
1990) and the increased AA supply is available for up to six hours, however, MPS 
appears to become unresponsive after 2.5 hours (Bohé et al., 2001). Another study 
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suggested this decrease in efficacy over time is due to desensitization of the signaling 
mechanism that senses and transmits information about AA availability. The authors 
further stated that long-term parenteral infusions of AAs will not maintain anabolism 
longer than a couple of hours and excess AAs are simply catabolized to urea. They 
warned that if studies are to obtain accurate values of human MPS, they need to be 
confined to periods of <3 hours, with 2.5 hours being optimal (Rennie et al., 2006). 
 
Since studies show stimulation of MPS is time limited (Bohé et al., 2001), it appears that 
only modest amounts of dietary amino acids would be needed to achieve maximal 
stimulation of the muscle anabolic processes (i.e., for adults of average weight, 30–40g of 
protein). The amount of protein necessary to build and maintain muscle can be easily 
obtained from a normal diet which is adequate to satisfy total energy needs for the 
individual since most diets contain at least 10-15% protein. Moreover, dietary protein 
consumed after exercise in excess of the amount which can be incorporated into muscle 
protein stimulates oxidation (Moore et al., 2009). 
 
Recent evidence suggests that physical training increases protein metabolism efficiency, 
whether moderate endurance exercise or resistance training. Endurance training does not 
increase leucine oxidation and protein metabolism becomes more efficient- increased 
protein balance is achieved at a lower rate of oxidation (Gaine et al., 2005).  
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Table 5: Summary of studies related to timing, dosing, and long-term effects of leucine 
supplementation 
Reference Population Design Findings 
Allen & Baker 
(1972) 
Chickens Chickens were fed 
varying amounts of excess 
leucine in their diets. 
The availability of the 
other BCAAs decreased 
as excess dietary leucine 
increased. 
Gatnau et al. 
(1995) 
Pigs Pigs were supplemented 
with varying levels of 
dietary leucine. 
High dietary leucine 
intake contributed to 
poor growth and 
immunity.  
Smith et al. 
(1998) 
23 young 
males 
Participants were given 
flooding doses of 
individual EAAs and non-
EAAs. 
Flooding doses of EAAs 
stimulated increased 
incorporation of tracers. 
Bohé et al. 
(2001) 
6 humans Mixed AAs were infused 
by IV. 
MPS rates declined 
rapidly after 2 hours. 
Gaine et al. 
(2005) 
7 humans Participants consumed a 
controlled diet and 
performed aerobic 
exercise for 4 weeks. 
Leucine oxidation 
decreased as protein 
utilization improved. 
Nguema et al. 
(2007) 
Rats Rats were fed long term 
diets with differing 
sources of protein. 
Diets composed of 
casein and supplemented 
with EAAs sustained 
appetite. 
Blouet et al. 
(2009) 
Rats Rats consumed a diet 
supplemented with leucine 
or a high protein diet. 
Increased leucine 
availability in 
mediobasal 
hypothalamus led to 
decreased food intake. 
Moore et al. 
(2009) 
6 young 
males 
Participants performed 
resistance exercise then 
consumed differing 
amounts of protein. 
Leucine oxidation 
increased after 20g 
protein as MPS was 
maximally stimulated. 
Churchward-
Venne et al. 
(2012) 
24 males Participants completed 
resistance exercise and 
consumed varying doses 
of whey supplemented 
with leucine or EAAs 
without leucine. 
Low doses of whey 
supplemented with 
leucine or EAAs 
stimulated MPS to the 
same degree as larger 
doses. 
Nelson et al. 
(2012) 
12 males Participants performed 
high intensity endurance 
exercise and subsequently 
ingested leucine/protein 
supplement or control. 
Supplemental leucine 
dose saturated BCAA 
metabolism, increased 
leucine oxidation, 
attenuated MPB. 
Yoshizawa et Rats Rats were supplemented Muscle phosphorylation 
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al. (2013) with oral leucine in 
varying doses. 
plateaued at 0.675 g/kg 
of body weight.  
BCAAs: Branched Chain Amino Acids; EAAs: Essential Amino Acids; AAs: Amino 
Acids; MPS: Muscle Protein Synthesis; MPB: Muscle Protein Breakdown 
 
In the studies compiled in Table 5, performed to assess the optimal timing and dosing of 
leucine supplementation and the long-term effects, the consensus was that leucine intake 
in excess of that found in ~20g whole dietary protein or ~0.75mg/kg free leucine is 
unnecessary. Other studies found the window to evaluate MPS post-exercise should be 
contained to 2.5 hours. There was little consensus and inadequate data to postulate on the 
effects of long-term leucine supplementation. 
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Effects After Resistance and Endurance Exercise 
 
Do the previously seen effects of leucine supplementation on MPS after exercise have 
consistent results despite varying types of exercise? Resistance exercise and training can 
have a remarkable effect on body composition by increasing muscular strength and 
hypertrophy. For hypertrophy to occur MPS must surpass muscle protein catabolism and 
as previously stated, availability of AAs is a chief factor in promoting protein synthesis 
(Norton & Layman, 2006; Rannels et al., 1974; Garlick & Grant, 1988). Significantly 
lower levels of serum AAs, predominantly leucine and isoleucine, have been noted 
following resistance training. Supplementing the diet with EAAs circumvents this decline 
and increases AA availability to the muscles.  
 
Studies that have examined the physiological mechanism of leucine efficacy identify 
messenger RNA translation via the activation of a variety of intracellular signaling 
proteins, especially those of the mTOR signaling cascade as the primary level of 
regulation of acute MPS.  Stimulation of MPS after food intake or exercise is 
accompanied by increased phosphorylation, and activity, of the mTOR signaling pathway 
(Karlsson et al., 2004; Kimball & Jefferson, 2004, 2006; Wilkinson et al., 2013; Coffey et 
al., 2011).  
 
Moore et al. (2009) examined the response of protein synthesis and total body leucine 
oxidation to increasing protein intake after an acute bout of resistance exercise. 
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Increasing protein intake stimulated muscle and plasma albumin protein synthesis in a 
dose-dependent manner up to 20g dietary protein, after which there was a significant 
stimulation of whole-body leucine oxidation and no added increase in protein synthesis. 
 
Given that energy needs are met, the findings by Moore et al. have implications for 
protein recommendations for athletes participating in resistance exercise in terms of the 
quantity of dietary protein to maximize muscle growth. If a 20g protein dose maximally 
stimulates MPS after exercise and resistance exercise enhances the synthesis of muscle 
protein for at least 24 hours, the question becomes: How often in a day should an athlete 
consume such a dose to stimulate muscle anabolism and maximize muscle growth? As 
MPS becomes refractory to continual aminoacidemia and excessive AAs are lost to 
oxidation, the authors speculated that 20g of high quality dietary protein could be 
ingested 5–6 times and MPS could be expected to be maximally stimulated. Consumption 
of protein in excess of this dose would just lead to oxidative loss. More importantly, 
given that AAs oxidation capacity adapts to diet and acts as a key regulator of protein 
stores, chronic excessive protein may actually lead to weakening of the protein synthetic 
response to protein doses less than the optimal 20g (Moore et al., 2009). 
 
The resistance exercise and EAA supplementation combination is an effective stimulator 
of protein synthesis (Biolo et al., 1997; Preedy & Garlick, 1986). Whey protein is a rich 
source of EAAs, including the BCAAs, and especially leucine. As a source of AAs, whey 
has been examined for potential ergogenic effects in combination with resistance training 
Burke et al., 2001). The purpose of a study by Coburn et al. (2006) was to examine the 
35 
 
 
 
effects of resistance training in conjunction with a leucine (6.2g) and whey protein (20g) 
supplement. Significantly greater strength increases were seen in the group consuming 
the leucine and whey supplement over those consuming a carbohydrate placebo. The two 
groups were not matched for protein intake, however, and these effects may be 
contributed solely to the addition of protein to leucine and whey supplemented group. 
 
In order to elucidate the efficacy of supplemental leucine and resistance exercise on 
muscle anabolism, Tipton et al. (2009) investigated the response of net muscle protein 
balance to ingestion of additional leucine with protein in association with resistance 
exercise. Subjects performed resistance exercise following ingestion of 1 of 2 drinks: 
placebo or 16.6g of whey protein + 3.4g of leucine. Whey protein plus leucine ingestion 
resulted in an elevated anabolic response in muscle, but not one that is greater than the 
response to whey protein alone. 
 
Researchers surmised that since protein synthesis results not only from provision of 
substrate for synthetic processes, but also from stimulation of signaling pathways in 
muscle cells, bolus doses cannot further stimulate protein synthesis once the signaling 
pathway thresholds are met. The anabolic pathways are likely fully stimulated by the 
amino acid provision of the whey protein and/or resistance exercise, so the additional 
leucine presents no further advantage (Tipton et al., 2009). 
 
Another study sought to investigate the effects of daily oral leucine ingestion on strength, 
lean tissue mass (LTM), and fat mass (FM) of subjects during a 12-week resistance-
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training program (Ispoglou et al., 2011). Participants ingested either 4g per day leucine or 
a corresponding amount of lactose and trained under supervision twice per week. 
Strength on each exercise was assessed by five repetition maximum, and body 
composition was assessed by DEXA. The leucine group demonstrated significantly 
higher strength gains, but there were no significant differences between groups in either 
total percentage LTM gains or FM losses. This research suggests that 4g per day leucine 
ingestion could be used as a supplement to enhance strength performance during 
resistance training. 
 
Koopman et al. (2007) also agreed that resistance exercise is a potent stimulus to 
augment muscle protein anabolism, but that the intake of food during post-exercise 
recovery is required for hypertrophy to take place. Interestingly, protein catabolism is 
stimulated to a greater extent than protein synthesis following exercise. In consequence, 
athletes need to consume sources of protein post-exercise to achieve a positive protein 
balance and maximize their skeletal muscle adaptive response. For this reason, 
carbohydrate and protein/AA ingestion during exercise recovery is part of an effective 
strategy to stimulate MPS, inhibit protein breakdown and, as a result, augment net muscle 
protein accretion. 
 
Kirby et al. (2012) focused on leucine’s ability to attenuate muscle damage, more so than 
its specific effect on MPS, but as previously discussed, muscle hypertrophy is a result of 
decreased muscle breakdown as well. Kirby et al. (2012) attempted to determine the 
effect of leucine supplementation on indices of muscle damage following eccentric-based 
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resistance exercise. Muscle function was determined by peak force during an isometric 
squat and by jump height. The leucine supplemented group experienced an attenuated 
drop in mean peak force compared to the placebo group. The principal discovery was that 
high-dose leucine supplementation was not able to attenuate the increase in biochemical 
markers of muscle damage that follows eccentric-based resistance exercise. It may, 
however, aid in maintaining isometric force output. 
 
Although some previously mentioned studies have seen positive results by combining 
leucine supplementation with carbohydrate ingestion (Dreyer et al., 2007; Coffey et al., 
2011), the following study utilized EAAs, which would theoretically further enhance 
MPS. This study evaluated whether EAA and carbohydrate ingestion before resistance 
exercise can improve direct measures of post-exercise MPS like fractional synthetic rate 
(FSR). Researchers found that muscle FSR was enhanced in the EAA + CHO group 
immediately following EAA + CHO ingestion, declined to basal values during exercise, 
and remained unchanged at 1-hour post-exercise. Muscle FSR decreased in the fasting 
group during exercise and increased at 1-hour post-exercise. The researchers concluded 
that EAA + CHO ingestion before resistance exercise did not enhance post-exercise FSR 
compared with exercise in a fasting state (Fujita et al., 2009). 
 
The effects of endurance exercise differ from those of resistance exercise, as endurance 
training generates lower muscle contractile forces and characteristically does not induce 
muscle hypertrophy (Phillips et al., 1996). Sustained endurance exercise is largely 
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catabolic and reduces MPS and plasma leucine concentrations during exercise due to the 
metabolic demand for BCAAs in training skeletal muscle (Norton & Layman, 2006).  
 
Provision of supplemental leucine during endurance exercise could stimulate greater 
post-exercise MPS by diverting protein utilization form endogenous stores (Pasiakos et 
al. 2011). In this study the effects of consuming an optimal EAA dose (consistent with 
high-quality proteins) supplemented with leucine during endurance exercise on MPS, 
intracellular signaling, and protein metabolism during recovery was assessed. Participants 
completed 2 bouts of cycle ergometry, and one of two isonitrogenous drinks with 
differing leucine contents [leucine+EAA, 3.5g leucine; EAA, 1.87g leucine] was 
consumed during exercise. MPS and protein turnover were determined by continuous 
tracer infusions. This trial found the supplement enhanced post-exercise MPS by 33% 
when compared with a control. These findings signify that increasing leucine content in 
an already optimal EAA dose results in further MPS increases following endurance 
exercise. Additional leucine availability may have spared endogenous protein stores to a 
greater extent than EAA alone, however, the EAA supplement plus leucine concentration 
did not improve mTORC1 intracellular signaling (Pasiakos et al., 2011). 
 
Thomson et al. (2011) attempted to establish how consuming leucine-rich protein and 
high carbohydrate post-exercise would affect recovery, as measured by subsequent 
cycling and mechanistic markers. Cyclists performed 2- to 2.5-hour interval training 
bouts, then ingesting leucine-enriched protein (0.1 & 0.4g/kg/hr), high carbohydrate 
(1.2g/kg/hr) nutrition or isocaloric control nutrition. Post-exercise leucine ingestion 
39 
 
 
 
improved mean sprint power by 2.5% and a reduction in creatine kinase (CK) activity 
was suggestive of attenuated disruption to skeletal muscle integrity and faster muscle 
repair. The findings are relevant to real life practice as the supplement was provided 
along with regular food items, ingested following exercise in a realistic time frame, and 
provided with an appropriate quantity of carbohydrate to optimize glycogen repletion 
(Thomson et al., 2011). 
 
While not directly researching leucine and MPS, a study by Greer et al. (2007) found 
BCAA ingestion prior to and during endurance exercise attenuated indices of muscle 
damage, which may have a limited effect on physical performance. Participants ingested 
a carbohydrate or BCAA beverage before, during, and after a 90 minute cycling bout. 
Lactate dehydrogenase (LDH) and CK measures of muscle damage were lower in the 
BCAA-supplemented group compared to placebo and carbohydrate groups, and leg-
flexion torque was higher at the 48-hour mark, possibly due to decreased muscle damage. 
If this exercise-induced muscle damage can be reduced by supplementation, then 
logically speaking, subsequent performance should improve or be maintained. 
 
One more study (Nelson et al., 2012) looking at leucine’s effects following endurance 
exercise used a leucine plus carbohydrate, fat, and protein supplement (7.5/20/89/22 
g/hour, respectively) and an isocaloric fat and carbohydrate control. Subjects ingested 
one of the supplements following high-intensity cycling and researchers measured repeat 
performance and muscle indices of damage and turnover. The leucine supplemented 
group saw greater plasma BCAA levels and leucine oxidation indicating the 10g leucine 
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dosage exceeded BCAA metabolism capacity. CK levels were lower in the experimental 
group, but the apparent effect on subsequent performance was “trivial” per the study 
authors. 
 
Table 6: Summary of studies related to effect of leucine supplementation on resistance 
versus endurance exercise 
Reference Population Design Findings 
Karlsson et 
al. (2004) 
7 males; age 
25 ± 1 yr 
Participants consumed a 
BCAA or placebo before 
and after performing 
resistance exercise. 
BCAA ingestion 
increased 
phosphorylation of 
signaling proteins in 
skeletal muscle. 
Coburn et al. 
(2006) 
33 males; age 
24.4  ± 2.4 yrs 
Participants consumed a 
leucine/whey or control 
supplement and performed 
resistance exercise. 
The supplement group 
saw greater strength 
increases. 
Dreyer et al. 
(2007) 
16 young 
males 
Participants consumed an 
EAA+CHO or control 
supplement 1 hour after 
resistance exercise. 
Enhanced mTOR 
signaling and FSR were 
seen in the EAA+CHO 
group. 
Greer et al. 
(2007) 
9 males; age 
21.6 ± 3.2 yrs 
Participants consumed 
BCAA, CHO, or placebo 
beverage before and during 
endurance cycling. 
BCAA supplementation 
attenuated CK and LDH 
concentrations. 
Koopman et 
al. (2008) 
8 elderly 
males; age 73 
± 1 yr 
Participants consumed a 
supplement with leucine or 
a control 30 min after 
resistance exercise. 
Whole body protein 
balance was greater in 
the leucine group, but 
FSR was not affected. 
Moore et al. 
(2009) 
6 males; age 
22 ± 2 yrs 
Participants consumed 
differing doses of whole 
egg protein after resistance 
exercise. 
MPS displayed a dose 
response to protein 
ingestion and was 
maximally stimulated at 
20g. 
Tipton et al. 
(2009) 
15 humans Participants performed 
resistance exercise after 
consuming placebo or 
leucine supplement 
Leucine stimulated MPS 
to a greater extent than 
placebo. 
Fujita et al. 
(2009) 
22 humans Participants either fasted or 
consumed EAA+ CHO 
prior to performing 
resistance exercise. 
EAA+CHO did not 
increase FSR 
postexercise compared 
to fasting. 
Coffey et al. 8 males; age Participants performed MPS and anabolic 
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(2011) 21.4 ± 2.6 yrs sprint cycling after 
consuming either 
whey+leucine+CHO or 
placebo. 
signaling was greater 
following the 
whey+leucine+CHO 
provision. 
Ispoglou  et 
al. (2011) 
26 males Participants consumed 
either leucine or lactose 
daily for 12 wks and 
performed resistance 
exercise 2x/wk. 
The leucine group had 
greater strength gains, 
but not LTM or FM 
losses. 
Pasiakos et 
al. (2011) 
8 humans; age 
24 ± 2 yrs 
Participants consumed 
either a low-leucine or 
high-leucine EAA 
supplement during 
endurance exercise. 
The leucine-enriched 
supplement induced 
greater MPS, less MPB, 
and greater oxidation. 
Thomson et 
al. (2011) 
10 males 
cyclists 
Participants performed 
endurance cycling and 
consumed leucine-enriched 
supplement or isocaloric 
control post-exercise. 
Post-exercise leucine 
ingestion improved 
sprint power and 
reduced perceived 
overall tiredness during 
sprints. 
Howatson et 
al. (2012) 
12 males; age 
23 ± 2 yrs  
Participants consumed a 
BCAA supplement or 
placebo and performed 
drop jumps. 
BCAA supplementation 
reduced indices of 
muscle damage and 
improved recovery time. 
Kirby et al. 
(2012) 
27 males; age 
21.3 ± 1.6 yrs 
Participants consumed 
leucine or placebo before, 
during, after performing 
depth jumps. 
The leucine group had 
an attenuated drop in 
mean peak force 
compared to placebo. 
Nelson et al. 
(2012) 
12 male 
cyclists 
Participants consumed a 
leucine-enriched 
supplement or isocaloric 
control after endurance 
exercise. 
Leucine ingestion 
increased BCAA 
oxidation, decreased CK 
concentration, and had 
trivial effect on sprint 
power. 
BCAA: Branched Chain Amino Acid; EAA: Essential Amino Acid; CHO: 
Carbohydrate; mTOR: Mammalian Target of Rapamycin; FSR: Fractional Synthetic 
Rate; CK: Creatine Kinase; LDH: Lactate Dehydrogenase; MPS: Muscle Protein 
Synthesis; LTM: Lean tissue mass; FM: Fat mass; MPB: Muscle Protein Breakdown 
 
These studies, compiled in Table 6, performed to assess the effect of leucine 
supplementation on resistance or endurance exercise, found supplementation in addition 
to exercise increased MPS in conjunction with resistance exercise and attenuated MPB in 
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conjunction with endurance exercise. The two studies (Fujita et al. 2009; Koopman et al. 
2008) in which leucine supplementation was not seen to have a greater effect than the 
control had no similar characteristics from which to draw conclusions as to the type of 
situation where leucine may be most effective. In summary, the studies shown in Table 6 
indicated leucine may improve subsequent performance in relation to both resistance and 
endurance exercises. 
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Conclusion 
 
Leucine has been shown throughout numerous studies over the last 30+ years to be an 
effective stimulator of MPS in varied populations and in different training scenarios 
(Buse & Reid, 1975; Casperson et al., 2012; Coburn et al., 2006; Dreyer, 2008; Katsanos 
et al., 2006; Pasiakos et al., 2011). This essential amino acid has been established as a 
potent regulator of metabolism, a signal in the mTOR transduction pathway, and of key 
importance in its ability to help spare endogenous protein stores (Alvestrand et al., 1990; 
Balage et al., 2011; Drummond & Rasmussen, 2008; Garlick, 2005; Kimball & Jefferson, 
2004; Louard et al., 1990). Many studies mentioned previously examined its role in 
protein metabolism and identified leucine as the most effective amino acid in activating 
MPS, preventing muscle breakdown, and maintaining positive net muscle protein. 
Leucine’s efficacy is not clear cut however, as there are many qualifications to consider.  
 
Some may assume since leucine is ingested on a daily basis and is found in many 
common foods, its isolated consumption would be beneficial and harbor no dangers. 
However, intake of isolated amino acids often leads to imbalances in these nutrients and 
can instigate deleterious effects in vivo. Normally, amino acids are consumed as a part of 
an entire meal, and that intake is accompanied by a resultant rise in blood glucose and 
insulin release, which have been found to facilitate leucine’s mechanism of action 
(Preedy & Garlick, 1986; Garlick & Grant, 1988; Li et al., 2013). This may be due to an 
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increase in the insulin sensitivity in cells post-meal caused by amino acid consumption. 
Researchers have surmised that as protein synthesis results not only from availability of 
substrates for synthetic processes, but also from activation of signaling pathways in cells, 
bolus doses cannot further increase protein synthesis once the signaling pathway 
thresholds are met (Drummond & Rasmussen, 2008). Bolus dosing of any amino acid, in 
particular leucine, could potentially lead to insulin resistance due to prolonged 
stimulation of the insulin response (Li et al., 2013). Also, as cells’ amino acids oxidation 
capacity adapts to dietary intake, chronic excessive intake could lead to blunting of the 
protein synthetic response to protein doses less than bolus intakes. 
 
Provided that total body energy requirements are met, leucine supplementation has a dose 
dependent protein synthesis response, a greater activation of synthetic signaling 
pathways, as well as the ability to spare body protein stores. MPS is stimulated 
immediately following intake while the amino acid pool is elevated, so studies have seen 
greater effects on muscle hypertrophy when leucine is consumed post-exercise than when 
it is consumed prior to activity. This is also because leucine appears to be more effective 
in stimulating MPS when muscle is in an anabolic state, as it is post-exercise (Anthony et 
al., 1999; Dreyer et al., 2008). 
 
Following either resistance or endurance exercise, leucine has been shown to be effective 
in stimulating muscle protein synthesis. It has been seen to be more effective as a post-
exercise supplement than water, an isocaloric carbohydrate supplement, lactose, an 
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isonitrogenous EAA supplement, or fasting (Churchward-Venne et al., 2012; Dreyer et 
al., 2008; Stock et al., 2010; Ispoglou et al., 2011). 
 
While hundreds of studies have been performed on leucine in various situations, a couple 
holes in the literature may still exist. To prevent some of the poor outcomes discussed 
here, an upper limit of leucine intake should be established or, preferably, a widely 
accepted recommendation for appropriate doses of high-quality protein as leucine is more 
effective when consumed as part of meal. The long-term effects of chronic leucine 
supplementation would be a study worth noting as well. An investigation into the effects 
of leucine intake prior to and following exercise may find a consistently elevated amino 
acid pool and continued FSR maintenance.  
 
In conclusion, adding high leucine foods, including whey, eggs, poultry, fish, and kidney 
beans, to meals during post-exercise recovery may aid in increasing muscle hypertrophy, 
attenuating muscle breakdown, and maintaining net positive muscle protein. Some 
studies have found that bolus doses of leucine are not more effective than doses that 
could be ingested from a healthy diet, and may induce detrimental health effects, 
including insulin resistance (Zanchi et al., 2012; McCormack et al., 2013). Others have 
found that increasing dietary leucine has a positive effect on insulin sensitivity (Li et al., 
2013; Zhang et al., 2012).  Despite the lingering questions regarding a potentially 
negative health impact with high dose intakes, consumption of high leucine foods and 
leucine-enhanced foods and supplements (e.g., whey protein food bars) post-exercise 
have been found to enhance muscle protein synthesis.
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